Wilson Sonsini Goodrich & Rosati advised Enable Injections on the deal.Enable Injections, Inc., a company developing and manufacturing the enFuse platform of investigational wearable drug delivery…
Enable Injections’ $215 Million Series C Financing


Wilson Sonsini Goodrich & Rosati advised Enable Injections on the deal.Enable Injections, Inc., a company developing and manufacturing the enFuse platform of investigational wearable drug delivery…
…